Immediate versus delayed application of bone morphogenetic protein-2 solution in damaged extraction sockets: a preclinical in vivo investigation

被引:3
|
作者
Kim, Myong Ji [1 ]
Cha, Jae-Kook [1 ]
Paeng, Kyeong-Won [1 ]
Song, Young Woo [1 ]
Thoma, Daniel S. [2 ]
Jung, Ronald E. [2 ]
Jung, Ui-Won [1 ]
机构
[1] Yonsei Univ, Res Inst Periodontal Regenerat, Dept Periodontol, Coll Dent, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Univ Zurich, Dent Sch, Dept Fixed & Removable Prosthodont & Dent Mat Sci, Zurich, Switzerland
基金
新加坡国家研究基金会;
关键词
Bone morphogenetic protein 2; Alveolar ridge augmentation; Bone substitutes; Animal experimentation; Tooth extraction; Damaged extraction socket; Extraction socket regeneration; TOOTH EXTRACTION; BIO-OSS(R) COLLAGEN; RIDGE PRESERVATION; REGENERATION; BMP-2; DYNAMICS; RHBMP-2;
D O I
10.1007/s00784-020-03362-w
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective To compare the clinical, radiographic, and histological healing patterns between the immediate and delayed applications of bone morphogenetic protein-2 (BMP-2) in damaged extraction sockets in dogs. Materials and methods The distal roots of the fourth premolars of the mandible were extracted bilaterally in five beagle dogs, and buccal bone defects (4 mm wide and 9 mm high) were surgically created. Collagenated biphasic calcium phosphate (CBCP) soaked for 10 min in 100 mu L of BMP-2 solution was applied immediately to the defect site in the control group. In the test group, the BMP-2 solution of same dose was injected into the grafted site 2 weeks after grafting with a saline-soaked CBCP. The dogs were sacrificed 2 weeks later. Clinical, histological, and radiographic analyses were followed. Results Swelling and inflammatory reactions were predominantly observed in the control group at 2 weeks. The area of new bone formation was significantly larger in the control group compared with the test group (10.8 +/- 7.0 mm(2) [mean +/- SD] and 6.3 +/- 3.1 mm(2), respectively; p = 0.043). No significant difference was found in ridge width at 2 mm, 4 mm and 6 mm below the lingual bone crest between the control (2.6 +/- 1.0 mm, 3.2 +/- 0.9 mm and 4.5 +/- 0.5 mm, respectively) and test group (3.3 +/- 1.0 mm, 3.7 +/- 1.3 mm and 4.2 +/- 1.0 mm; all p > 0.05). Conclusions Delayed application of BMP-2 2 weeks after surgery did not show any advantage over immediate application of BMP-2 in terms of new bone formation.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 23 条
  • [1] Immediate versus delayed application of bone morphogenetic protein-2 solution in damaged extraction sockets: a preclinical in vivo investigation
    Myong Ji Kim
    Jae-Kook Cha
    Kyeong-Won Paeng
    Young Woo Song
    Daniel S. Thoma
    Ronald E. Jung
    Ui-Won Jung
    Clinical Oral Investigations, 2021, 25 : 275 - 282
  • [2] Alveolar Ridge Regeneration With Open Versus Closed Healing in Damaged Extraction Sockets: A Preclinical In Vivo Study
    Choi, Jae-Won
    Park, Jin-Young
    Cha, Jae-Kook
    Hieu, Pham-Duong
    Jung, Hwi-Dong
    Kim, Chang-Sung
    CLINICAL ORAL IMPLANTS RESEARCH, 2025, 36 (02) : 220 - 227
  • [3] Bone healing following immediate versus delayed placement of titanium implants into extraction sockets: A prospective clinical study
    Schropp, L
    Kostopoulos, L
    Wenzel, A
    INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS, 2003, 18 (02) : 189 - 199
  • [4] An Atomistic Investigation of Adsorption of Bone Morphogenetic Protein-2 on Gold with Nanoscale Topographies
    Marquetti, Izabele
    Desai, Salil
    SURFACES, 2022, 5 (01): : 176 - 185
  • [5] Effectiveness of xenogeneic and synthetic bone-block substitute materials with/without recombinant human bone morphogenetic protein-2: A preclinical study using a rabbit calvarium model
    Lim, Hyun-Chang
    Paeng, Kyeong-Won
    Jung, Ui-Won
    Benic, Goran I.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2021, 48 (08) : 1126 - 1136
  • [6] Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation
    Fiorellini, JP
    Howell, TH
    Cochran, D
    Malmquist, J
    Lilly, LC
    Spagnoli, D
    Toljanic, J
    Jones, A
    Nevins, M
    JOURNAL OF PERIODONTOLOGY, 2005, 76 (04) : 605 - 613
  • [7] Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo
    Suliman, Salwa
    Xing, Zhe
    Wu, Xujun
    Xue, Ying
    Pedersen, Torbjorn O.
    Sun, Yang
    Doskeland, Anne P.
    Nickel, Joachim
    Waag, Thilo
    Lygre, Henning
    Finne-Wistrand, Anna
    Steinmueller-Nethl, Doris
    Krueger, Anke
    Mustafa, Kamal
    JOURNAL OF CONTROLLED RELEASE, 2015, 197 : 148 - 157
  • [8] COMPARATIVE, OSTEOCHONDRAL DEFECT REPAIR: STEM CELLS VERSUS CHONDROCYTES VERSUS BONE MORPHOGENETIC PROTEIN-2, SOLELY OR IN COMBINATION
    Reyes, R.
    Pec, M. K.
    Sanchez, E.
    del Rosario, C.
    Delgado, A.
    Evora, C.
    EUROPEAN CELLS & MATERIALS, 2013, 25 : 351 - 365
  • [9] Silk Fibroin Microparticles as Carriers for Delivery of Human Recombinant Bone Morphogenetic Protein-2: In Vitro and In Vivo Bioactivity
    Bessa, Paulo Cesar
    Balmayor, Elizabeth R.
    Hartinger, Joachim
    Zanoni, Gerald
    Dopler, Daniela
    Meinl, Alexandra
    Banerjee, Asmita
    Casal, Margarida
    Redl, Heinz
    Reis, Rui L.
    van Griensven, Martijn
    TISSUE ENGINEERING PART C-METHODS, 2010, 16 (05) : 937 - 945
  • [10] In vivo osteoinductivity of gelatin β-tri-calcium phosphate sponge and bone morphogenetic protein-2 on an equine third metacarpal bone defect
    Tsuzuki, N.
    Otsuka, K.
    Seo, J.
    Yamada, K.
    Haneda, S.
    Furuoka, H.
    Tabata, Y.
    Sasaki, N.
    RESEARCH IN VETERINARY SCIENCE, 2012, 93 (02) : 1021 - 1025